Inventor
PHADKE AVINASH
US44 patents
⚠️ This page may combine multiple inventors who share the name “PHADKE AVINASH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACHILLION PHARMACEUTICALS INC
29 patentsUS10301336B2May 28, 2019
Phosphonate compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC27 citations98
US10100072B2Oct 16, 2018
Phosphonate compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC27 citations98
US7906619B2Mar 15, 2011
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC51 citations98
US10092547B2Oct 9, 2018
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections
ACHILLION PHARMACEUTICALS INC19 citations94
US10689409B2Jun 23, 2020
Amino compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC9 citations93
US9273082B2Mar 1, 2016
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
ACHILLION PHARMACEUTICALS INC14 citations92
US7767706B2Aug 3, 2010
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC23 citations92
US7476686B2Jan 13, 2009
Substituted aryl thioureas and related compounds; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC23 citations92
US7094807B2Aug 22, 2006
Substituted aryl thioureas and related compounds; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC20 citations92
US9474742B2Oct 25, 2016
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
ACHILLION PHARMACEUTICALS INC3 citations84
US9468629B2Oct 18, 2016
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
ACHILLION PHARMACEUTICALS INC3 citations84
US9447132B2Sep 20, 2016
Highly active nucleoside derivative for the treatment of HCV
ACHILLION PHARMACEUTICALS INC16 citations84
US9233136B2Jan 12, 2016
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC9 citations84
US9227952B2Jan 5, 2016
Sovaprevir polymorphs and methods of manufacture thereof
ACHILLION PHARMACEUTICALS INC8 citations84
US9115175B2Aug 25, 2015
Processes for Producing sovaprevir
ACHILLION PHARMACEUTICALS INC9 citations84
US9006423B2Apr 14, 2015
Process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
ACHILLION PHARMACEUTICALS INC8 citations84
US7439374B2Oct 21, 2008
Azabenzofuran substituted thioureas; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC11 citations84
US7718671B2May 18, 2010
Substituted arylthiourea derivatives useful as inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC10 citations83
US7365068B2Apr 29, 2008
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC11 citations83
US9085607B2Jul 21, 2015
ACH-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof
ACHILLION PHARMACEUTICALS INC11 citations81
US11807627B2Nov 7, 2023
Morphic forms of complement factor D inhibitors
ACHILLION PHARMACEUTICALS INC5 citations74
US11814363B2Nov 14, 2023
Morphic forms of danicopan
ACHILLION PHARMACEUTICALS INC3 citations73
US10961252B2Mar 30, 2021
Quinazoline and indole compounds to treat medical disorders
ACHILLION PHARMACEUTICALS INC2 citations73
US9592222B2Mar 14, 2017
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
ACHILLION PHARMACEUTICALS INC2 citations73
US11248000B2Feb 15, 2022
Quinazoline and indole compounds to treat medical disorders
ACHILLION PHARMACEUTICALS INC0 citations63
US9833440B2Dec 5, 2017
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
ACHILLION PHARMACEUTICALS INC1 citations63
US9610317B2Apr 4, 2017
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
ACHILLION PHARMACEUTICALS INC0 citations52
US9540346B2Jan 10, 2017
Sovaprevir polymorphs and methods of manufacture thereof
ACHILLION PHARMACEUTICALS INC0 citations52
US9481708B2Nov 1, 2016
Process for producing Sovaprevir
ACHILLION PHARMACEUTICALS INC0 citations52
WILES JASON ALLAN
3 patentsUS8809313B2Aug 19, 2014
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
WILES JASON ALLAN15 citations92
US9125904B1Sep 8, 2015
Biphenyl imidazoles and related compounds useful for treating HCV infections
WILES JASON ALLAN17 citations83
US8835456B1Sep 16, 2014
NS5A inhibitors useful for treating HCV
WILES JASON ALLAN8 citations83
PHADKE AVINASH
3 patentsUS9133115B2Sep 15, 2015
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
PHADKE AVINASH10 citations83
US8785378B2Jul 22, 2014
Macrocyclic peptides as inhibitors of viral replication
PHADKE AVINASH9 citations83
US8614180B2Dec 24, 2013
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
PHADKE AVINASH14 citations83
MIRAVANT PHARM INC
2 patentsUS6794505B1Sep 21, 2004
Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
MIRAVANT PHARM INC20 citations92
US7521551B2Apr 21, 2009
Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
MIRAVANT PHARM INC0 citations51